Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of DiaSorin LIAISON® PTX3 (Long Pentraxin 3) Assay in Patients With Pneumonia

NCT06491004 is registered in ClinicalTrials.gov with Diasorin Italia S.p.A. as lead sponsor.

NCT NCT06491004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06491004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of DiaSorin LIAISON® PTX3 (Long Pentraxin 3) Assay in Patients With Pneumonia
Lead sponsor
Diasorin Italia S.p.A.
Phase
Observational
Overall status
Completed
Start date
September 20, 2021
Completion date
March 29, 2024
Enrollment
281 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia